Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes
Hagens Berman Sobol Shapiro: Suit Filed Against Bristol-Myers Squibb Over Tequin
August 18th, 2007
Hagens Berman Sobol Shapiro filed a lawsuit today against Bristol-Myers Squibb (NYSE:BMY) and Schering Corporation (NYSE:SGP), claiming its antibiotic drug Tequin causes severe blood-sugar issues in some patients which could lead to debilitating long-term healthcare issues including diabetes, and death. Tequin and its generic equivalent gatifloxacin was commonly prescribed for sinus, lung, and urinary tract infections, as well as other illnesses. According to Rob Carey, lead attorney from HBSS, safety concerns regarding Tequin began to surface in 2001, two years after the drug was approved by the Food and Drug Administration, when medical literature...
Source: Law & Health Weekly (2007-08-18)
|
